Moderate-to-Severe Psoriasis

Author:   John Y. M. Koo (University of California at San Francisco, USA) ,  Chai Sue Lee ,  Mark G. Lebwohl (Mount Sinai School of Medicine, New York, New York, USA) ,  Ethan C. Levin (University of California at San Francisco, USA)
Publisher:   Taylor & Francis Inc
Edition:   3rd New edition
ISBN:  

9781420088670


Pages:   414
Publication Date:   22 December 2008
Replaced By:   9781482215168
Format:   Hardback
Availability:   Awaiting stock   Availability explained


Our Price $607.20 Quantity:  
Add to Cart

Share |

Moderate-to-Severe Psoriasis


Add your own review!

Overview

Written by experts in the dermatology field, the new Third Edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and new pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. With 80 high quality color figures and full color throughout, this stand-alone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to the Third Edition: the addition of chapters on the use of infliximab, efalizumab, and Humera, as well as the latest status of clinical trials the most up-to-date phototherapy and laser treatment modalities stronger coverage of psoriatic arthritis

Full Product Details

Author:   John Y. M. Koo (University of California at San Francisco, USA) ,  Chai Sue Lee ,  Mark G. Lebwohl (Mount Sinai School of Medicine, New York, New York, USA) ,  Ethan C. Levin (University of California at San Francisco, USA)
Publisher:   Taylor & Francis Inc
Imprint:   Informa Healthcare
Edition:   3rd New edition
Dimensions:   Width: 15.20cm , Height: 2.00cm , Length: 22.90cm
Weight:   0.794kg
ISBN:  

9781420088670


ISBN 10:   142008867
Pages:   414
Publication Date:   22 December 2008
Audience:   Professional and scholarly ,  Professional & Vocational ,  Professional & Vocational
Replaced By:   9781482215168
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Awaiting stock   Availability explained

Table of Contents

1. An Overview of Psoriasis. 2. Evaluating Psoriasis in Patients. 3. Topical Agents in the Treatment of Moderate-to-Severe Psoriasis. 4. The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe Psoriasis. 5. Systemic and Topical PUVA Therapy. 6. Therapy of Moderate-to-Severe Psoriasis with Methotrexate. 7. Systemic Retinoids. 8. Cyclosporine in the Treatment of Severe Psoriasis. 9. Combination, Rotational, and Sequential Therapy. 10. Pediatric Psoriasis. 11. Psoriatic Arthritis. 12. Etanercept for Treatment of Psoriasis and Psoriatic Arthritis. 13. Adalimumab in the Treatment of Psoriasis. 14. Infliximab in the Treatment of Psoriasis. 15. Efalizumab in the Treatment of Psoriasis. 16. Alefacept for Treatment of Psoriasis. 17. Ustekinumab and ABT-874. 18. The Immunomodulatory/Immunosuppressive Classification System. 19. Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of Psoriasis.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List